Shikonin NEW
| Price | $29 | $44 | $89 |
| Package | 5mg | 10mg | 25mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-19 |
Product Details
| Product Name: Shikonin | CAS No.: 517-89-5 |
| Purity: 99.9% | Supply Ability: 10g |
| Release date: 2024/11/19 |
Product Introduction
Bioactivity
| Name | Shikonin |
| Description | Shikonin (Anchusa acid) is a natural product, a TMEM16A chloride channel inhibitor (IC50=6.5 μM) and selective PKM2 inhibitor. Shikonin exhibits antitumor, anti-inflammatory and wound healing activities. |
| Cell Research | U87 and U251 cells are seeded into 96-well plates at a density of 1×104 cells per well in standard DMEM and incubated for 24 h under standard conditions (37°C and 5% CO2). Then the medium is replaced with either blank, serum-free DMEM or DMEM containing Shikonin at concentrations of 2.5, 5, and 7.5 μM. The total volume in each well is 200 μL. Finally, the plates are shaken softly and the optical density is recorded at 570 nm (OD570) using a plate reader. At least three independent experiments are performed[4]. |
| Animal Research | Healthy male Sprague-Dawley rats (n=30; 8 to 10-weeks old, 250 to 300 g) are used in this study. Rats were randomly assigned to three groups: Sham-operated group (n=10), osteoarthritis model group (n=10) and Shikonin-treated group (n=10). In the sham-operated group, the right knee joint of the anesthetized rat is only exposed under sterile conditions, and the rats are treated with 0.1 ml/100 g physiological saline (i.p.). In the osteoarthritis model group, osteoarthritis model rats were treated with 0.1 ml/100 g physiological saline (i.p.). In the Shikonin-treated group, osteoarthritis model rats are treated with 10 mg/kg Shikonin (i.p.) once daily for 4 days after osteoarthritis modeling[5]. |
| In vitro | METHODS: Human glioma cells U87 and U251 were treated with Shikonin (2.5-7.5 μmol/L) for 12-72 h. Cell viability was measured by CCK-8. RESULTS: Shikonin inhibited the proliferation of U87 and U251 cells in a time- and dose-dependent manner. [1] METHODS: Macrophages RAW264.7 were pretreated with Shikonin (0.5-2 μM) for 1 h, then treated with LPS (250 ng/mL) and IFN-γ (100 ng/mL) for 24 h. Inflammatory factor levels were measured using RT-qPCR and ELISA. RESULTS: In LPS+IFN-γ-mimicked RAW264.7 cells, mRNA and protein expression of IL-1β, IL-6 and TNF-α were reduced. [2] |
| In vivo | METHODS: To investigate the efficacy against murine colitis, Shikonin (6.125-25 mg/kg) was administered by gavage to a DSS-induced Balb/c mouse model of colitis once daily for seven days. RESULTS: Shikonin attenuated the overall symptoms of DSS-induced colitis in mice and reduced colonic injury. [2] METHODS: To detect anti-tumor activity in vivo, Shikonin (0.1-10 mg/kg) was administered intraperitoneally to SCID mice bearing human melanoma B16 once daily for nine days. RESULTS: Shikonin treatment inhibited B16 cell growth in SCID mice in a dose-dependent manner. [3] |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 57 mg/mL H2O : Insoluble Ethanol : 13 mg/mL (45.1 mM) 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 5.7 mg/mL (19.77 mM), Suspension. Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. |
| Keywords | Inhibitor | Nuclear factor-kappaB | inhibit | TNFR | Human immunodeficiency virus | HIV | Cl? Channels | Isoarnebin-4 | TNF Receptor | Pyruvate Kinase | Isoarnebin4 | Tumor Necrosis Factor Receptor | Nuclear factor-κB | NSC-252844 | Shikonin | Chloride Channel | NF-κB | NSC252844 |
| Inhibitors Related | Stavudine | 5-Fluorouracil | Emtricitabine | Kaempferol | Dolutegravir intermediate-1 | Dextran sulfate sodium salt (MW 4500-5500) | Lamivudine | Diethylmaleate | Glucosamine | Lidocaine hydrochloride | Apremilast | Tenofovir |
| Related Compound Libraries | Traditional Chinese Medicine Monomer Library | Bioactive Compound Library | Selected Plant-Sourced Compound Library | Anti-Viral Compound Library | Anti-Inflammatory Traditional Chinese Medicine Compound Library | Inhibitor Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-virus Traditional Chinese Medicine Monomer Library | Ion Channel Targeted Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $79.00/1kg |
VIP1Y
|
Hebei Zhuanglai Chemical Trading Co Ltd
|
2024-11-21 | |
| $0.00/25KG |
VIP5Y
|
Hebei Mojin Biotechnology Co., Ltd
|
2024-10-10 | |
| $0.00/1KG |
VIP2Y
|
Wuhan Haorong Biotechnology Co.,Ltd
|
2023-08-07 | |
| $0.00/1KG |
VIP3Y
|
Changsha Staherb Natural Ingredients Co., Ltd.
|
2022-09-23 | |
| $110.00/1kg |
Hebei baicao biology science and technology co., ltd
|
2022-05-07 | ||
| $300.00/1KG |
VIP4Y
|
ZhenYiBio Technology Inc
|
2022-02-09 | |
| $10.00/1KG |
Hebei Zhanyao Biotechnology Co. Ltd
|
2021-10-15 | ||
| $235.00/1Kg/Bag |
VIP4Y
|
XI'AN TIANGUANGYUAN BIOTECH CO., LTD.
|
2021-07-05 | |
| $0.00/1g |
VIP4Y
|
Wuhan Nutra Biotechnology Co.,Ltd
|
2021-05-21 | |
| $0.00/20mg |
Shanghai Standard Technology Co., Ltd.
|
2020-08-12 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY